Ablation Frontiers

company

About

A develops and markets cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$21.80M
Industries
Biopharma,Biotechnology,Health Care,Manufacturing,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

Ablation Frontiers, Inc. (www.ablationfrontiers.com) is a medical device company based in Carlsbad, Calif., dedicated to helping individuals suffering from AF and other cardiac arrhythmias. In 2006, Ablation Frontiers received CE Mark to begin marketing its system of catheters and the GENius™ Radiofrequency (RF) Generator in the European Union to treat supraventricular arrhythmias and for use in atrioventricular node ablation. Ablation Frontiers is conducting a clinical trial under a United States Food and Drug Administration (FDA) investigational device exemption (IDE) to gain approval of the catheter system for permanent/long-standing persistent/chronic AF in the United States. Ablation Frontiers products are not approved for marketing or sales in the United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$40.47M
Ablation Frontiers has raised a total of $40.47M in funding over 2 rounds. Their latest funding was raised on Jul 17, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 17, 2007 Series C $21.80M 2 Detail
Feb 24, 2006 Series B $15.07M 1 Detail
Jun 22, 2004 Series A $3.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Ablation Frontiers is funded by 2 investors. Trellis Health Ventures and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Trellis Health Ventures Series C
Versant Ventures Series C